Towards polypharmacokinetics: Pharmacokinetics of multicomponent drugs and herbal medicines using a metabolomics approach

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Lan, Ke ^a   Xie, Guoxiang ^b   Jia, Wei ^b  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ARECAIDINE; ARECOLINE; CITALOPRAM; CLOZAPINE; COMPOUND DRUG; CYCLOPHOSPHAMIDE; DEXTROMETHORPHAN; FENOFIBRATE; FERULIC ACID; IFOSFAMIDE; ISOLIQUIRITIGENIN; MELATONIN; NEFAZODONE; PARACETAMOL; PROCAINAMIDE; PULEGONE; SINAPIC ACID; THIOTEPA; TIPRANAVIR; TOLCAPONE; UNCLASSIFIED DRUG; VALPROIC ACID; XENOBIOTIC AGENT;

ABSORPTION; BACTERIAL METABOLISM; CONCEPTUAL FRAMEWORK; DIET SUPPLEMENTATION; HERBAL MEDICINE; HUMAN; IN VIVO STUDY; METABOLOMICS; NONHUMAN; PHARMACOKINETICS; POLYPHARMACOKINETICS; PRIORITY JOURNAL; REVIEW;

EID: 84876567681     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/819147     Document Type: Review

References (110)

1. Blaylock R. L., New developments in phytoprevention and treatment of cancer. The Journal of the American Nutraceutical Association 1999 2 19 29
2. Hollander J. M., Mechanick J. I., Complementary and alternative medicine and the management of the metabolic syndrome. Journal of the American Dietetic Association 2008 108 3 495 509 2-s2.0-39649103205 10.1016/j.jada.2007.12.007 (Pubitemid 351288621)
3. Chan K., Progress in traditional Chinese medicine. Trends in Pharmacological Sciences 1995 16 6 182 187 2-s2.0-0028997733 10.1016/S0165-6147(00)89019-7
4. Plumb G. W., Garcia-Conesa M. T., Kroon P. A., Rhodes M., Ridley S., Williamson G., Metabolism of chlorogenic acid by human plasma, liver, intestine and gut microflora. Journal of the Science of Food and Agriculture 1999 79 3 390 392 10.1002/(SICI)1097-0010(19990301)79:3<390::AID-JSFA258>3.0.CO;2-0 (Pubitemid 29150582)
5. He S. M., Chan E., Zhou S. F., ADME properties of herbal medicines in humans: evidence, challenges andstrategies. Current Pharmaceutical Design 2011 17 4 357 407 2-s2.0-79958290393 10.2174/138161211795164194
6. Xie G., Zhao A., Zhao L., Chen T., Chen H., Qi X., Zheng X., Ni Y., Cheng Y., Lan K., Yao C., Qiu M., Jia W., Metabolic fate of tea polyphenols in humans. Journal of Proteome Research 2012 11 6 3449 3457 10.1021/pr300318m
7. Xue T., Roy R., Studying traditional Chinese medicine. Science 2003 300 5620 740 741 2-s2.0-0038333169 10.1126/science.300.5620.740 (Pubitemid 36532092)
8. Nassar A. E. F., Talaat R. E., Strategies for dealing with metabolite elucidation in drug discovery and development. Drug Discovery Today 2004 9 7 317 327 2-s2.0-1642368205 10.1016/S1359-6446(03)03018-6 (Pubitemid 38373651)
9. Pelkonen O., Tolonen A., Korjamo T., Turpeinen M., Raunio H., From known knowns to known unknowns: predicting in vivo drug metabolites. Bioanalysis 2009 1 2 393 414 2-s2.0-78650757034
10. Tolonen A., Turpeinen M., Pelkonen O., Liquid chromatography-mass spectrometry in in vitro drug metabolite screening. Drug Discovery Today 2009 14 3-4 120 133 2-s2.0-58849124556 10.1016/j.drudis.2008.11.002
11. Lindon J. C., Holmes E., Nicholson J. K., Metabonomics: systems biology in pharmaceutical research and development. Current Opinion in Molecular Therapeutics 2004 6 3 265 272 2-s2.0-3242879742 (Pubitemid 38997127)
12. Nicholson J. K., Lindon J. C., Systems biology: metabonomics. Nature 2008 455 7216 1054 1056 2-s2.0-54549091125 10.1038/4551054a
13. Nicholson J. K., Wilson I. D., Understanding "global" systems biology: metabonomics and the continuum of metabolism. Nature Reviews Drug Discovery 2003 2 8 668 676 2-s2.0-0043069547 (Pubitemid 37361770)
14. Wang Y., Tang H., Nicholson J. K., Hylands P. J., Sampson J., Holmes E., A metabonomic strategy for the detection of the metabolic effects of chamomile (Matricaria recutita L.) ingestion. Journal of Agricultural and Food Chemistry 2005 53 2 191 196 2-s2.0-12344311533 10.1021/jf0403282 (Pubitemid 40129901)
15. Sumner L. W., Urbanczyk-Wochniak E., Broeckling C. D., Metabolomics data analysis, visualization, and integration. Methods in Molecular Biology 2007 406 409 436 2-s2.0-40549100747 (Pubitemid 351367185)
16. Xie G., Plumb R., Su M., Xu Z., Zhao A., Qiu M., Long X., Liu Z., Jia W., Ultra-performance LC/TOF MS analysis of medicinal Panax herbs for metabolomic research. Journal of Separation Science 2008 31 6-7 1015 1026 2-s2.0-43249119417 10.1002/jssc.200700650 (Pubitemid 351649827)
17. Wu S. C., Yen G. C., Wang B. S., Chiu C. K., Yen W. J., Chang L. W., Duh P. D., Antimutagenic and antimicrobial activities of pu-erh tea. LWT-Food Science and Technology 2007 40 3 506 512 2-s2.0-33750491265 10.1016/j.lwt.2005. 11.008 (Pubitemid 44649255)
18. Wang B. S., Yu H. M., Chang L. W., Yen W. J., Duh P. D., Protective effects of pu-erh tea on LDL oxidation and nitric oxide generation in macrophage cells. LWT-Food Science and Technology 2008 41 6 1122 1132 2-s2.0-40649122519 10.1016/j.lwt.2007.07.002 (Pubitemid 351374946)
19. Ni Y., Su M., Lin J., Wang X., Qiu Y., Zhao A., Chen T., Jia W., Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress. FEBS Letters 2008 582 17 2627 2636 2-s2.0-46749154158 10.1016/j.febslet.2008.06.040
20. Chen X. Q., Ye Y., Cheng H., Yin J. F., Sun C., Comparative analysis of theanine, caffein and polyphenolic constituents in green tea, black tea and puer tea. Food Research and Development 2007 28 12 141 144
21. Lan K., Jia W., An Integrated metabolomics and pharmacokinetics strategy for multi-component drugs evaluation. Current Drug Metabolism 2010 11 1 105 114 2-s2.0-77950803183 10.2174/138920010791110926
22. Wei X., Shi X., Kim S., Zhang L., Patrick J. S., Binkley J., McClain C., Zhang X., Data preprocessing method for liquid chromatography-mass spectrometry based metabolomics. Analytical Chemistry 2012 84 18 7963 7971 10.1021/ac3016856
23. Trygg J., Holmes E., Lundstedt T., Chemometrics in metabonomics. Journal of Proteome Research 2007 6 2 469 479 2-s2.0-33847369007 10.1021/pr060594q (Pubitemid 46340151)
24. Ma S., Chowdhury S. K., Analytical strategies for assessment of human metabolites in preclinical safety testing. Analytical Chemistry 2011 83 13 5028 5036 2-s2.0-79960013720 10.1021/ac200349g
25. Wang Y., Wang S., Liu Y., Yan L., Dou G., Gao Y., Characterization of metabolites and cytochrome P450 isoforms involved in the microsomal metabolism of aconitine. Journal of Chromatography B 2006 844 2 292 300 2-s2.0-33751215189 10.1016/j.jchromb.2006.07.059 (Pubitemid 44792009)
26. Zhao Y. F., Song F. R., Guo X. H., Liu S. Y., Studies on the biotransformation of aconitine in human intestinal bacteria using soft-ionization mass spectrometry. Chemical Journal of Chinese Universities 2008 29 1 55 59 2-s2.0-42449147516
27. Tang L., Ye L., Lv C., Zheng Z., Gong Y., Liu Z., Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes. Toxicology Letters 2011 202 1 47 54 2-s2.0-79952040477 10.1016/j.toxlet.2011.01.019
28. Wang X., Pi Z., Liu W., Zhao Y., Liu S., Effect of pH on the metabolism of aconitine under rat intestinal bacteria and analysis of metabolites using HPLC/MS-MSn technique. Chinese Journal of Chemistry 2010 28 12 2494 2500 2-s2.0-78651292683 10.1002/cjoc.201190028
29. Plumb R. S., Stumpf C. L., Granger J. H., Castro-Perez J., Haselden J. N., Dear G. J., Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids. Rapid Communications in Mass Spectrometry 2003 17 23 2632 2638 2-s2.0-0345095459 (Pubitemid 37498776)
30. Idborg H., Edlund P. O., Jacobsson S. P., Multivariate approaches for efficient detection of potential metabolites from liquid chromatography/mass spectrometry data. Rapid Communications in Mass Spectrometry 2004 18 9 944 954 2-s2.0-2442517316 (Pubitemid 38619544)
31. Chen C., Gonzalez F. J., Idle J. R., LC-MS-based metabolomics in drug metabolism. Drug Metabolism Reviews 2007 39 2-3 581 597 2-s2.0-34548388291 10.1080/03602530701497804 (Pubitemid 47355739)
32. Patterson A. D., Gonzalez F. J., Idle J. R., Xenobiotic metabolism: a view through the metabolometer. Chemical Research in Toxicology 2010 23 5 851 860 2-s2.0-77952337695 10.1021/tx100020p
33. Johnson C. H., Patterson A. D., Idle J. R., Gonzalez F. J., Xenobiotic metabolomics: major impact on the metabolome. Annual Review of Pharmacology and Toxicology 2012 52 37 56 10.1146/annurev-pharmtox-010611-134748
34. Chen C., Meng L., Ma X., Krausz K. W., Pommier Y., Idle J. R., Gonzalez F. J., Urinary metabolite profiling reveals CYP1A2-mediated metabolism of NSC686288 (aminoflavone). Journal of Pharmacology and Experimental Therapeutics 2006 318 3 1330 1342 2-s2.0-33747584882 10.1016/j.sse.2006.06.008
35. Giri S., Idle J. R., Chen C., Zabriskie T. M., Krausz K. W., Gonzalez F. J., A metabolomic approach to the metabolism of the areca nut alkaloids arecoline and arecaidine in the mouse. Chemical Research in Toxicology 2006 19 6 818 827 2-s2.0-33745320763 10.1021/tx0600402 (Pubitemid 43939061)
36. Chen C., Ma X., Malfatti M. A., Krausz K. W., Kimura S., Felton J. S., Idle J. R., Gonzalez F. J., A comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach. Chemical Research in Toxicology 2007 20 3 531 542 2-s2.0-34047250288 10.1021/tx600320w (Pubitemid 46548699)
37. Giri S., Krausz K. W., Idle J. R., Gonzalez F. J., The metabolomics of (±)-arecoline 1-oxide in the mouse and its formation by human flavin-containing monooxygenases. Biochemical Pharmacology 2007 73 4 561 573 2-s2.0-33845925755 10.1016/j.bcp.2006.10.017 (Pubitemid 46038850)
38. Fardet A., Llorach R., Orsoni A., Martin J. F., Pujos-Guillot E., Lapierre C., Scalbert A., Metabolomics provide new insight on the metabolism of dietary phytochemicals in rats. Journal of Nutrition 2008 138 7 1282 1287 2-s2.0-46249121333 (Pubitemid 351930990)
39. Chen C., Krausz K. W., Idle J. R., Gonzalez F. J., Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice. Journal of Biological Chemistry 2008 283 8 4543 4559 2-s2.0-41949134860 10.1074/jbc.M706299200
40. Cheng J., Ma X., Krausz K. W., Idle J. R., Gonzalez F. J., Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity. Drug Metabolism and Disposition 2009 37 8 1611 1621 2-s2.0-67650831245 10.1124/dmd.109.027565
41. Sun J., Schnackenberg L. K., Beger R. D., Studies of acetaminophen and metabolites in urine and their correlations with toxicity using metabolomics. Drug Metabolism Letters 2009 3 3 130 136 2-s2.0-70350728809 10.2174/ 187231209789352139
42. Li F., Lu J., Ma X., Profiling the reactive metabolites of xenobiotics using metabolomic technologies. Chemical Research in Toxicology 2011 24 5 744 751 2-s2.0-79956160306 10.1021/tx200033v
43. Lutz U., Bittner N., Lutz R. W., Lutz W. K., Metabolite profiling in human urine by LC-MS/MS: method optimization and application for glucuronides from dextromethorphan metabolism. Journal of Chromatography B 2008 871 2 349 356 2-s2.0-48749091970 10.1016/j.jchromb.2008.04.018
44. Ma X., Chen C., Krausz K. W., Idle J. R., Gonzalez F. J., A metabolomic perspective of melatonin metabolism in the mouse. Endocrinology 2008 149 4 1869 1879 2-s2.0-41549100628 10.1210/en.2007-1412 (Pubitemid 351468324)
45. 1-acetyl-5-methoxy-kynuramine formation from melatonin in mice. Journal of Pineal Research 2010 49 2 106 114 2-s2.0-77955140547 10.1111/j.1600-079X.2010.00771.x
46. Cho J. Y., Kang D. W., Ma X., Ahn S. H., Krausz K. W., Luecke H., Idle J. R., Gonzalez F. J., Metabolomics reveals a novel vitamin E metabolite and attenuated vitamin E metabolism upon PXR activation. Journal of Lipid Research 2009 50 5 924 937 2-s2.0-67649690494 10.1194/jlr.M800647-JLR200
47. Liu A., Chen Y., Yang Z., Feng Y., Rui W., Luo W., Liu Y., Gonzalez F. J., Dai R., New metabolites of fenofibrate in SpragueDawley rats by UPLC-ESI-QTOF-MS-based metabolomics coupled with LC-MS/MS. Xenobiotica 2009 39 4 345 354 2-s2.0-66149144731 10.1080/00498250802680827
48. Liu A., Patterson A. D., Yang Z., Zhang X., Liu W., Qiu F., Sun H., Krausz K. W., Idle J. R., Gonzalez F. J., Dai R., Fenofibrate metabolism in the cynomolgus monkey using ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabolomics. Drug Metabolism and Disposition 2009 37 6 1157 1163 2-s2.0-66649118903 10.1124/dmd.108.025817
49. Sun J., Von Tungeln L. S., Hines W., Beger R. D., Identification of metabolite profiles of the catechol-O-methyl transferase inhibitor tolcapone in rat urine using LC/MS-based metabonomics analysis. Journal of Chromatography B 2009 877 24 2557 2565 2-s2.0-67650726440 10.1016/j.jchromb.2009.06.033
50. Li F., Patterson A. D., Höfer C. C., Krausz K. W., Gonzalez F. J., Idle J. R., Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics. Biochemical Pharmacology 2010 80 7 1063 1074 2-s2.0-77955660756 10.1016/j.bcp.2010.06.002
51. Li F., Wang L., Guo G. L., Ma X., Metabolism-mediated drug interactions associated with ritonavir-boosted tipranavir in mice. Drug Metabolism and Disposition 2010 38 5 871 878 2-s2.0-77950947376 10.1124/dmd.109.030817
52. Schneider R. P., Zhang H., Mu L., Kalgutkar A. S., Bonner R., Utility of multivariate analysis in support of in vitro metabolite identification studies: retrospective analysis using the antidepressant drug nefazodone. Xenobiotica 2010 40 4 262 274 2-s2.0-77949477767 10.3109/00498251003592691
53. Sun J., Schnackenberg L. K., Hansen D. K., Beger R. D., Study of valproic acid-induced endogenous and exogenous metabolite alterations using LC-MS-based metabolomics. Bioanalysis 2010 2 2 207 216 2-s2.0-79952514795 10.4155/bio.09.173
54. Li F., Ma X., Metabolomic screening and identification of the bioactivation pathways of ritonavir. Chemical Research in Toxicology 2011 24 12 2109 2114 10.1021/tx2004147
55. Li F., Patterson A. D., Höfer C. C., Krausz K. W., Gonzalez F. J., Idle J. R., A comprehensive understanding of thioTEPA metabolism in the mouse using UPLC-ESI-QTOFMS-based metabolomics. Biochemical Pharmacology 2011 81 8 1043 1053 2-s2.0-79952992201 10.1016/j.bcp.2011.01.024
56. Tan G., Lou Z., Dong X., Li W., Chai Y., Urinary metabolites of isoliquiritigenin in wistar rats using UHPLC-TOF-MS-based xenometabolomics. Chromatographia 2011 74 3-4 341 348 10.1007/s10337-011-2072-9
57. Shi X., Yao D., Chen C., Identification of N-acetyltaurine as a novel metabolite of ethanol through metabolomics-guided biochemical analysis. Journal of Biological Chemistry 2012 287 9 6336 6349 10.1074/jbc.M111.312199
58. Li F., Patterson A. D., Krausz K. W., Metabolomics reveals the metabolic map of procainamide in humans and mice. Biochemical Pharmacology 2012 83 10 1435 1444 10.1016/j.bcp.2012.02.013
59. Zhen Y., Slanař O., Krausz K. W., Chen C., Slavík J., McPhail K. L., Zabriskie T. M., Perlík F., Gonzalez F. J., Idle J. R., 3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio. Drug Metabolism and Disposition 2006 34 9 1563 1574 2-s2.0-33747869604 10.1124/dmd.105.008920 (Pubitemid 44285399)
60. Llorach-Asunción R., Jauregui O., Urpi-Sarda M., Andres-Lacueva C., Methodological aspects for metabolome visualization and characterization. A metabolomic evaluation of the 24 h evolution of human urine after cocoa powder consumption. Journal of Pharmaceutical and Biomedical Analysis 2010 51 2 373 381 2-s2.0-70349795716 10.1016/j.jpba.2009.06.033
61. Llorach R., Garrido I., Monagas M., Urpi-Sarda M., Tulipani S., Bartolome B., Andres-Lacueva C., Metabolomics study of human urinary metabolome modifications after intake of almond (Prunus dulcis (Mill.) D.A. Webb) skin polyphenols. Journal of Proteome Research 2010 9 11 5859 5867 2-s2.0-78149388236 10.1021/pr100639v
62. Xie G., Ye M., Wang Y., Ni Y., Su M., Huang H., Qiu M., Zhao A., Zheng X., Chen T., Jia W., Characterization of pu-erh tea using chemical and metabolic profiling approaches. Journal of Agricultural and Food Chemistry 2009 57 8 3046 3054 2-s2.0-65349180282 10.1021/jf804000y
63. van Velzen E. J. J., Westerhuis J. A., van Duynhoven J. P. M., van Dorsten F. A., Hoefsloot H. C. J., Jacobs D. M., Smit S., Draijer R., Kroner C. I., Smilde A. K., Multilevel data analysis of a crossover designed human nutritional intervention study. Journal of Proteome Research 2008 7 10 4483 4491 2-s2.0-55949118718 10.1021/pr800145j
64. van Velzen E. J. J., Westerhuis J. A., van Duynhoven J. P. M., van Dorsten F. A., Grün C. H., Jacobs D. M., Duchateau G. S. M. J. E., Vis D. J., Smilde A. K., Phenotyping tea consumers by nutrikinetic analysis of polyphenolic end-metabolites. Journal of Proteome Research 2009 8 7 3317 3330 2-s2.0-67650400688 10.1021/pr801071p
65. Martin F. P. J., Rezzi S., Peré-Trepat E., Kamlage B., Collino S., Leibold E., Kastler J., Rein D., Fay L. B., Kochhar S., Metabolic effects of dark chocolate consumption on energy, gut microbiota, and stress-related metabolism in free-living subjects. Journal of Proteome Research 2009 8 12 5568 5579 2-s2.0-71549121959 10.1021/pr900607v
66. Croixmarie V., Umbdenstock T., Cloarec O., Moreau A., Pascussi J. M., Boursier-Neyret C., Walther B., Integrated comparison of drug-related and drug-induced ultra performance liquid chromatography/mass spectrometry metabonomic profiles using human hepatocyte cultures. Analytical Chemistry 2009 81 15 6061 6069 2-s2.0-68049093084 10.1021/ac900333e
67. Li H., Zhou M., Zhao A., Jia W., Traditional Chinese medicine: balancing the gut ecosystem. Phytotherapy Research 2009 23 9 1332 1335 2-s2.0-69749117578 10.1002/ptr.2590
68. Li P., Liu E.-H., Wen X.-D., Analysis of Chinese herbal medicines with holistic approaches and integrated evaluation models. TrAC-Trends in Analytical Chemistry 2008 27 1 66 77 10.1016/j.trac.2007.11.005
69. Xin G.-Z., Qi L.-W., Shi Z.-Q., Wang G.-J., Shang J., Strategies for integral metabolism profile of multiple compounds in herbal medicines: pharmacokinetics, metabolites characterization and metabolic interactions. Current Drug Metabolism 2011 12 9 809 817
70. Li C. Y., Qi L. W., Li P., Correlative analysis of metabolite profiling of Danggui Buxue Tang in rat biological fluids by rapid resolution LC-TOF/MS. Journal of Pharmaceutical and Biomedical Analysis 2011 55 1 146 160 2-s2.0-79951735696 10.1016/j.jpba.2010.12.034
71. Xiang C., Qiao X., Wang Q., Guo D., Ye M., From single compounds to herbal extract: a strategy to systematically characterize the metabolites of licorice in rats. Drug Metabolism and Disposition 2011 39 9 1597 1608 10.1124/dmd.111.038695
72. Qiao X., Ye M., Xiang C., Wang Q., Miao W.-J., Guo D.-A., Analytical strategy to reveal the in vivo process of multi-component herbal medicine: a pharmacokinetic study of licorice using liquid chromatography coupled with triple quadrupole mass spectrometry. Journal of Chromatography A 2012 1258 84 93 10.1016/j.chroma.2012.08.041
73. Gong P., Cui N., Wu L., Liang Y., Xu X., Tang W., Wang G., Hao H., Chemicalome and metabolome matching approach to elucidating biological metabolic networks of complex mixtures. Analytical Chemistry 2012 84 6 2995 3002 10.1021/ac3002353
74. Smilde A. K., Westerhuis J. A., Hoefsloot H. C. J., Bijlsma S., Rubingh C. M., Vis D. J., Jellema R. H., Pijl H., Roelfsema F., van der Greef J., Dynamic metabolomic data analysis: a tutorial review. Metabolomics 2010 6 1 3 17 2-s2.0-77949284307 10.1007/s11306-009-0191-1
75. Westerhuis J. A., van Velzen E. J. J., Hoefsloot H. C. J., Smilde A. K., Multivariate paired data analysis: multilevel PLSDA versus OPLSDA. Metabolomics 2010 6 1 119 128 2-s2.0-77949308124 10.1007/s11306-009-0185-z
76. van Duynhoven J., Vaughan E. E., Jacob D. M., Gross G., Roger L. C., Possemiers S., Smilde A. K., Doré J., Westerhuis J. A., van de Wiele T., Metabolic fate of polyphenols in the human superorganism. Proceedings of the National Academy of Sciences of the United States of America 2011 108 supplement 1 4531 4538 10.1073/pnas.1000098107
77. van Duynhoven J. P. M., van Velzena E. J. J., Westerhuis J. A., Nutrikinetics: concept, technologies, applications, perspectives. Trends in Food Science and Technology 2012 26 1 4 13 10.1016/j.tifs.2012.01.004
78. Llorach R., Garcia-Aloy M., Tulipani S., Andres-Lacueva C., Nutrimetabolomic strategies to develop new biomarkers of intake and health effects. Journal of Agricultural and Food Chemistry 2012 60 36 8797 8808 10.1021/jf301142b
79. Lenz E. M., Wilson I. D., Analytical strategies in metabonomics. Journal of Proteome Research 2007 6 2 443 458 2-s2.0-33847358695 10.1021/pr0605217 (Pubitemid 46340149)
80. van der Greef J., Perspective: all systems go. Nature 2011 480 7378 S87 10.1038/480S87a
81. Ideker T., Galitski T., Hood L., A new approach to decoding life: systems biology. Annual Review of Genomics and Human Genetics 2001 2 343 372 2-s2.0-0035775725 10.1146/annurev.genom.2.1.343 (Pubitemid 35265011)
82. Kitano H., Systems biology: a brief overview. Science 2002 295 5560 1662 1664 2-s2.0-0036500993 10.1126/science.1069492 (Pubitemid 34202893)
83. Lan K., Zhang Y., Yang J., Xu L., Simple quality assessment approach for herbal extracts using high performance liquid chromatography-UV based metabolomics platform. Journal of Chromatography A 2010 1217 8 1414 1418 2-s2.0-74949121654 10.1016/j.chroma.2009.12.031
84. Wang Z., Hu H., Chen F., Metabolic profiling assisted quality assessment of Rhodiola rosea extracts by high-performance liquid chromatography. Planta Medica 2012 78 7 740 746 10.1055/s-0031-1298373
85. Duan L.-X., Li M., Chen M., Cui G.-H., Jia W., Huang L.-Q., Qi X., Use of the metabolomics approach to characterize chinese medicinal material Huangqi. Molecular Plant 2012 5 2 376 386 10.1093/mp/ssr093
86. Wang M., Lamers R. J. A. N., Korthout H. A. A. J., van Nesselrooij J. H. J., Witkamp R. F., van der Heijden R., Voshol P. J., Havekes L. M., Verpoorte R., van der Greef J., Metabolomics in the context of systems biology: Bridging Traditional Chinese Medicine and molecular pharmacology. Phytotherapy Research 2005 19 3 173 182 2-s2.0-20444478277 10.1002/ptr.1624 (Pubitemid 40827637)
87. Zhang A., Sun H., Wang Z., Sun W., Wang P., Wang X., Metabolomics: towards understanding traditional Chinese medicine. Planta Medica 2010 76 17 2026 2035 2-s2.0-78649908579 10.1055/s-0030-1250542
88. Wang X., Sun H., Zhang A., Sun W., Wang P., Wang Z., Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. Journal of Pharmaceutical and Biomedical Analysis 2011 55 5 859 868 2-s2.0-79956151568 10.1016/j.jpba.2011.01.042
89. Liu P., Liu S., Tian D., Wang P., The applications and obstacles of metabonomics in traditional Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2012 2012 4 945824 10.1155/2012/945824
90. Wu T., Yang M., Wei H.-F., He S.-H., Wang S.-C., Ji G., Application of metabolomics in traditional chinese medicine differentiation of deficiency and excess syndromes in patients with diabetes mellitus. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 968083 10.1155/2012/968083
91. Jové M., Serrano J. C. E., Ortega N., Ayala V., Anglès N., Reguant J., Morelló J. R., Romero M. P., Motilva M. J., Prat J., Pamplona R., Portero-Otín M., Multicompartmental LC-Q-TOF-based metabonomics as an exploratory tool to identify novel pathways affected by polyphenol-rich diets in mice. Journal of Proteome Research 2011 10 8 3501 3512 2-s2.0-79961217470 10.1021/pr200132s
92. Turnbaugh P. J., Ley R. E., Hamady M., Fraser-Liggett C. M., Knight R., Gordon J. I., The Human Microbiome Project. Nature 2007 449 7164 804 810 2-s2.0-35348968286 10.1038/nature06244 (Pubitemid 47598620)
93. Qin J., Li R., Raes J., A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010 464 7285 59 65
94. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D. R., Fernandes G. R., Tap J., Bruls T., Batto J. M., Bertalan M., Borruel N., Casellas F., Fernandez L., Gautier L., Hansen T., Hattori M., Hayashi T., Kleerebezem M., Kurokawa K., Leclerc M., Levenez F., Manichanh C., Nielsen H. B., Nielsen T., Pons N., Poulain J., Qin J., Sicheritz-Ponten T., Tims S., Torrents D., Ugarte E., Zoetendal E. G., Wang J., Guarner F., Pedersen O., De Vos W. M., Brunak S., Doré J., Weissenbach J., Ehrlich S. D., Bork P., Enterotypes of the human gut microbiome. Nature 2011 473 7346 174 180 2-s2.0-79955906805 10.1038/nature09944
95. Consortium T. H. M. P., A framework for human microbiome research. Nature 2012 486 7402 215 221
96. Consortium T. H. M. P., Structure, function and diversity of the healthy human microbiome. Nature 2012 486 7402 207 214
97. Rosabelle McManus I., Contag A. O., Olson R. E., Characterization of endogenous ethanol in the mammal. Science 1960 131 3393 102 103 2-s2.0-0000846815
98. Spinucci G., Guidetti M., Lanzoni E., Pironi L., Endogenous ethanol production in a patient with chronic intestinal pseudo-obstruction and small intestinal bacterial overgrowth. European Journal of Gastroenterology and Hepatology 2006 18 7 799 802 2-s2.0-33745244799 10.1097/01.meg.0000223906.55245. 61
99. Compare D., Coccoli P., Rocco A., Nardone O. M., De Maria S., Nardone G., Gut-liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutrition, Metabolism and Cardiovascular Diseases 2012 22 6 471 476 10.1016/j.numecd.2012.02.007
100. Martin F. P. J., Dumas M. E., Wang Y., Legido-Quigley C., Yap I. K. S., Tang H., Zirah S., Murphy G. M., Cloarec O., Lindon J. C., Sprenger N., Fay L. B., Kochhar S., van Bladeren P., Holmes E., Nicholson J. K., A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Molecular Systems Biology 2007 3, article 112 2-s2.0-34249036137 10.1038/msb4100153 (Pubitemid 46801777)
101. Martin F. P. J., Wang Y., Sprenger N., Yap I. K. S., Lundstedt T., Lek P., Rezzi S., Ramadan Z., van Bladeren P., Fay L. B., Kochhar S., Lindon J. C., Holmes E., Nicholson J. K., Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Molecular Systems Biology 2008 4, article 157 2-s2.0-38349078772 10.1038/msb4100190
102. Martin F. P. J., Sprenger N., Yap I. K. S., Wang Y., Bibiloni R., Rochat F., Rezzi S., Cherbut C., Kochhar S., Lindon J. C., Holmes E., Nicholson J. K., Panorganismal gut microbiome-host metabolic crosstalk. Journal of Proteome Research 2009 8 4 2090 2105 2-s2.0-65249154282 10.1021/pr801068x
103. Martin F. P. J., Wang Y., Yap I. K. S., Sprenger N., Lindon J. C., Rezzi S., Kochhar S., Holmes E., Nicholson J. K., Topographical variation in murine intestinal metabolic profiles in relation to microbiome speciation and functional ecological activity. Journal of Proteome Research 2009 8 7 3464 3474 2-s2.0-67650394402 10.1021/pr900099x
104. Zheng X., Xie G., Zhao A., Zhao L., Yao C., Chiu N. H. L., Zhou Z., Bao Y., Jia W., Nicholson J. K., Jia W., The footprints of gut microbial-mammalian co-metabolism. Journal of Proteome Research 2011 10 12 5512 5522 10.1021/pr2007945
105. Nicholson J. K., Holmes E., Burcelin R., Pettersson S., Host-gut microbiota metabolic interactions. Science 2012 336 6086 1262 1267 10.1126/science.1223813
106. Wilson I. D., Nicholson J. K., The role of gut microbiota in drug response. Current Pharmaceutical Design 2009 15 13 1519 1523 2-s2.0-67650595188 10.2174/138161209788168173
107. Clayton T. A., Baker D., Lindon J. C., Everett J. R., Nicholson J. K., Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proceedings of the National Academy of Sciences of the United States of America 2009 106 34 14728 14733 2-s2.0-70149096873 10.1073/pnas.0904489106
108. Meinl W., Sczesny S., Brigelius-Flohé R., Blaut M., Glatt H., Impact of gut microbiota on intestinal and hepatic levels of phase 2 xenobiotic-metabolizing enzymes in the rat. Drug Metabolism and Disposition 2009 37 6 1179 1186 2-s2.0-66649100229 10.1124/dmd.108.025916
109. Björkholm B., Bok C. M., Lundin A., Rafter J., Hibberd M. L., Pettersson S., Intestinal microbiota regulate xenobiotic metabolism in the liver. PLoS ONE 2009 4 9 2-s2.0-70349108406 10.1371/journal.pone.0006958 e6958
110. Peters S., Janssen H. G., Vivó-Truyols G., Trend analysis of time-series data: a novel method for untargeted metabolite discovery. Analytica Chimica Acta 2010 663 1 98 104 2-s2.0-77951622627 10.1016/j.aca.2010.01.038